NGM Biopharmaceuticals, Inc. Profile Avatar - Palmy Investing

NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an enginee…

Biotechnology
US, South San Francisco [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

NGM Biopharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

NGM Biopharmaceuticals, Inc. can't present revenue by segment

End of NGM's Analysis
CIK: 1426332 CUSIP: 62921N105 ISIN: US62921N1054 LEI: - UEI: -
Secondary Listings
NGM has no secondary listings inside our databases.